Inflammatory pseudotumor of the urinary bladder presenting as a symptom of active vasculitis in a patient with granulomatosis with polyangiitis (Wegener’s) – an unusual manifestation of ANCA-associated vasculitis
Authors:
Jakub Řezáč 1; Zdenka Hrušková 1; Pavel Konopásek 1; Eva Honsová 2; Martin Mašek 3; Romana Ryšavá 1; Vladimír Tesař 1
Authors place of work:
Klinika nefrologie 1. LF UK a VFN, Praha
1; Pracoviště klinické a transplantační patologie IKEM, Praha
2; Radiodiagnostická klinika 1. LF UK a VFN, Praha
3
Published in the journal:
Ces Urol 2014; 18(3): 240-245
Category:
Case report
Summary
Granulomatosis with polyangiitis (GPA) is the most common type of ANCA-associated vasculitides (AAV) occurring in the Czech Republic. AAV are (predominantly) small-vessel vasculitides that can afflict any organ in the human body. Urogenital involvement is relatively rare and can cause diagnostic challenge. This is a case report of a female patient with GPA presenting with urinary bladder pseudotumour. Urinary bladder carcinoma was initially suspected. Its differentiation from localized inflammatory process caused by active vasculitis was very important as the treatment of GPA includes potentially toxic cyclophosphamide. Establishment of the right diagnosis was enabled by assessment of the bio-psy by experienced pathologist. As documented by serial repeated CT scans, immunosuppressive therapy led to complete regression of the finding in the urinary bladder.
Conclusion:
GPA symptoms vary widely and may mimic cancer. Right and timely diagnosis of GPA may save the patient from an unnecessary surgical procedure or even chemotherapy.
Key words:
ANCA, granulomatosis with polyangiitis, urinary bladder, tumour, vasculitis.
Zdroje
1. Lynch JP, Tazelaar H. Wegener Granulomatosis (Granulomatosis With Polyangiitis). Semin Respir Crit Care Med 2011; 32(3): 274–297.
2. Habermann TM. Mayo Clinic internal medicine review, 2006–2007. 7. Ed. Mayo Clinic Scientific Press; 935.
3. Boomsma MM, Stegeman CA, van der Leij MJ, et al. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000; 43(9): 2025–2033.
4. Lynch JP III, White E, Tazelaar H, Langford CA. Wegener’s granulomatosis: evolving concepts in treatment. Semin Respir Crit Care Med 2004; 25(5): 491–521.
5. Frausová D, Brejníková M, Šafránková H, Hrušková Z, Tesař V. Masivní gastrointestinální krvácení u pacientky s Wegenerovou granulomatózou – kazuistika. Čes. Revmatol. 2009; 17(4): 214–217.
6. Aasarød K, Bostad L, Hammerstrøm J, Jørstad S, Iversen BM. Renal histopathology and clinical course in 94 patients with Wegener’s granulomatosis. Nephrol Dial Transplant 2001; 16(5): 953–960.
7. Knight A, Askling J, Granath F, et al. Urinary bladder cancer in Wegener’s granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 2004; 63: 1307–1311.
8. Hooda D, Parsons J, Hooda S, Nuss M, Layne R. Isolated bladder vasculitis: a rare presentation of Wegener’s granulomatosis. West Virginia Medical Journal 2011; 107(1): 24–25.
9. Hellmich B, Kausch I, Doehn C, Jocham D, Holl-Ulrich K, Gross WL. Urinary bladder cancer in Wegener’s granulomatosis: is it more than cyclophosphamide? Ann Rheum Dis 2004; 63: 1183–1185.
10. Travis LB, Curtis RE, Glimelius B, et al. Bladder and Kidney Cancer Following Cyclophosphamide Therapy Non-Hodgkin’s Lymphoma. Journal of the National Cancer Institute 1995; 87(7): 524–531.
Štítky
Paediatric urologist Nephrology UrologyČlánok vyšiel v časopise
Czech Urology
2014 Číslo 3
Najčítanejšie v tomto čísle
- Varicocele
- Age specific PSA and PSA velocity – comparison on the basis of prostate biopsies
- Active surveillance in prostate cancer
- Penile tissue preserving methods in the treatment of lower T categories of penile cancer